Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$598.03 USD
-17.66 (-2.87%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $598.05 +0.02 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$598.03 USD
-17.66 (-2.87%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $598.05 +0.02 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $525.63 in the latest trading session, marking a +0.47% move from the prior day.
Here's Why You Should Retain Thermo Fisher (TMO) Stock Now
by Zacks Equity Research
Investors are optimistic about Thermo Fisher's (TMO) strong end market growth and noteworthy acquisitions.
3 Gene Sequencing Stocks With Potential to Gain in 2H22
by Indrajit Bandyopadhyay
Here we look at three stocks, PKI, TMO and TXG, with robust genome sequencing capabilities that investors can keep a watch on.
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $553.76, marking a -0.41% move from the previous day.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $543.28, moving +1.37% from the previous trading session.
Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $544.81 in the latest trading session, marking a +0.78% move from the prior day.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $519.22, moving +1.11% from the previous trading session.
Thermo Fisher Scientific (TMO) Stock Moves -1.92%: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $504.89 in the latest trading session, marking a -1.92% move from the prior day.
Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $507.45, marking a -0.87% move from the previous day.
The Zacks Analyst Blog Highlights Exxon Mobil, Coca-Cola, Thermo Fisher Scientific, The Progressive, and Dominion Energy
by Zacks Equity Research
Exxon Mobil, Coca-Cola, Thermo Fisher Scientific, The Progressive, and Dominion Energy have been included in this Analyst Blog.
Top Stock Reports for Exxon Mobil, Coca-Cola & Thermo Fisher
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), The Coca-Cola Company (KO), and Thermo Fisher Scientific Inc. (TMO).
Thermo Fisher's (TMO) Autoimmune Disease Test Gets FDA Nod
by Zacks Equity Research
Thermo Fisher's (TMO) RNA Polymerase III and EliA Rib-P blood tests are intended to diagnose systemic sclerosis and systemic lupus erythematosus.
Thermo Fisher (TMO) to Promote Mass Spectrometry Imaging
by Zacks Equity Research
Thermo Fisher's (TMO) new deal with TransMIT will advance the use of the AP-SMALDI5 AF ion source with Orbitrap MS technology for spatial multi-omics applications.
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed the most recent trading day at $560.66, moving +1.41% from the previous trading session.
Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $552.88, marking a -0.94% move from the previous day.
Why Is Tandem Diabetes Care, Inc. (TNDM) Down 16.3% Since Last Earnings Report?
by Zacks Equity Research
Tandem Diabetes Care, Inc. (TNDM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why You Should Retain Thermo Fisher (TMO) for Now
by Zacks Equity Research
Investors are optimistic about Thermo Fisher's (TMO) robust y/y revenue growth in the Analytical Instruments, and the Laboratory Products and Biopharma Services segments.
Thermo Fisher (TMO) North America Sales Grow, Margin Woe Stays
by Zacks Equity Research
Thermo Fisher (TMO) witnesses core business strength across segments, end markets, and geographies.
Thermo Fisher (TMO) to Advance Precision Medicine in Qatar
by Zacks Equity Research
Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.
Top Research Reports for Microsoft, Micron Technology & UBS
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Micron Technology, Inc. (MU), and UBS Group AG (UBS).
Should You Invest in the iShares U.S. Medical Devices ETF (IHI)?
by Zacks Equity Research
Sector ETF report for IHI
Thermo Fisher (TMO) End Markets Strong, Margin Under Pressure
by Zacks Equity Research
Thermo Fisher's (TMO) core business strength was broad-based across segments, end markets, and geographies.
The Zacks Analyst Blog Highlights Microsoft, Meta Platforms, Thermo Fisher Scientific, Berkshire Hathaway, and HSBC Holdings
by Zacks Equity Research
Microsoft, Meta Platforms, Thermo Fisher Scientific, Berkshire Hathaway, and HSBC Holdings are part of top Analyst Blog.
Top Research Reports for Microsoft, Meta Platforms & Thermo Fisher Scientific
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Meta Platforms, Inc. (FB), and Thermo Fisher Scientific Inc. (TMO).